Enterprise Financial Services Corp (EFSC)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-118	Closed	-$1K	–	1056
2015 Q4	$1K	Hold	118	–	–	﹤0.01%	1002
2015 Q3	$1K	Hold	118	–	–	﹤0.01%	980
2015 Q2	$2K	Hold	118	–	–	﹤0.01%	883
2015 Q1	$1K	Hold	118	–	–	﹤0.01%	1118
2014 Q4	$1K	Hold	118	–	–	﹤0.01%	1130
2014 Q3	$1K	Hold	118	–	–	﹤0.01%	1108
2014 Q2	$2K	Hold	118	–	–	﹤0.01%	1029
2014 Q1	$1K	Buy	+118	New	+$1.26K	﹤0.01%	1155

Other funds holding BCRX

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s BCRX Position: Q1 2016 in Review

Enterprise Financial Services Corp (EFSC) sold out of BioCryst Pharmaceuticals (BCRX) in Q1 2016, closing a stake of 118 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in BCRX in Q1 2014 and held it in 8 quarters. The position peaked at $2K in Q2 2015. 109 funds tracked by Wall St. Rank hold BCRX as of Q1 2016.

Enterprise Financial Services Corp (EFSC) reported no remaining BioCryst Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Enterprise Financial Services Corp (EFSC) sold 118 BioCryst Pharmaceuticals shares in Q1 2016, an estimated $1K.
Enterprise Financial Services Corp (EFSC) first reported a position in BioCryst Pharmaceuticals in Q1 2014 and held it in 8 quarters.
Enterprise Financial Services Corp (EFSC)'s BioCryst Pharmaceuticals position peaked at $2K in Q2 2015.
109 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q1 2016.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q1 2016, filed 29 Apr 2016.